Vascular mortality in participants of a bipolar genomics study

Jess G Fiedorowicz1, Dubravka Jancic2, James B Potash2

  • 1Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA; Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA; Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA.

Psychosomatics
|April 22, 2014
PubMed

Insights

Longer depressive episodes in bipolar disorder significantly increase the risk of vascular mortality. This suggests mood disorders accelerate cardiovascular and cerebrovascular death in a dose-dependent manner.

Area of Science:

  • Psychiatry
  • Cardiology
  • Epidemiology

Background:

  • Previous research linked symptom burden in bipolar disorder to adverse vascular outcomes.
  • This study aimed to confirm these findings using a practical measure of mood disorder duration and vascular mortality.

Purpose of the Study:

  • To investigate the association between the duration of depressive and manic episodes and vascular mortality in individuals with bipolar I disorder.
  • To replicate prior findings on the relationship between mood disorder chronicity and vascular outcomes.

Main Methods:

  • Mortality assessment of 1716 participants with bipolar I disorder using the National Death Index.
  • Cox proportional hazards models were used to analyze the relationship between episode duration and time to vascular mortality, adjusting for covariates.

Main Results:

  • Over a mean follow-up of 7 years, 18 vascular deaths occurred among 58 total deaths.
  • Longer duration of severe depressive episodes was significantly associated with increased vascular mortality (HR=1.16, p=0.02).
  • The duration of manic episodes did not show a significant association with vascular mortality.

Conclusions:

  • The duration of severe depression independently predicts vascular mortality in bipolar disorder.
  • Findings support the hypothesis that mood disorders accelerate vascular mortality in a dose-dependent manner.
  • Further research into mechanisms and integrated treatment strategies for mood and cardiovascular risk factors is recommended.
Abstract

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
706